Skip to playerSkip to main content
  • 15 hours ago
Blocking the P2X7 receptor has shown to significantly reduce neuroinflammation, according to latest research. This finding may pave the way for new therapies targeting Alzheimer's, Parkinson's, and mental health conditions linked to brain inflammation.

Category

🗞
News
Transcript
00:00Blocking a single receptor cut inflammation in human brain tissue by up to 50%.
00:04This discovery could reshape treatment for diseases like Alzheimer's and Parkinson's.
00:09Researchers at the University of Birmingham found the P2X7 receptor triggers
00:14harmful inflammatory proteins in brain cells.
00:17Using tissue from neurosurgery, they showed that a drug blocking this receptor
00:21reduces inflammation significantly.
00:24Professor Nicholas Barnes called it a major step toward repurposing existing therapeutics
00:29to combat neuroinflammation at its source.
00:32The team also created microglia-like cells from blood samples
00:36to study brain immune responses more precisely.
00:39This breakthrough opens the door to clinical trials targeting brain inflammation
00:43in conditions with no current treatments.
00:46Disclosure. This video contains stock footage and content created or enhanced
00:49using AI-assisted tools.

Recommended